137 related articles for article (PubMed ID: 9933855)
1. Anti-Rh D activity of commercial intravenous immunoglobulin preparations.
Turner CE; Thorpe SJ; Brasher MD; Thorpe R
Vox Sang; 1999; 76(1):55-8. PubMed ID: 9933855
[TBL] [Abstract][Full Text] [Related]
2. Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity.
Thorpe SJ; Fox BJ; Dolman CD; Lawrence J; Thorpe R
Vox Sang; 2003 Aug; 85(2):80-4. PubMed ID: 12925158
[TBL] [Abstract][Full Text] [Related]
3. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products.
Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
Vox Sang; 2009 Aug; 97(2):160-8. PubMed ID: 19402856
[TBL] [Abstract][Full Text] [Related]
4. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method.
Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189
[TBL] [Abstract][Full Text] [Related]
5. International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in intravenous immunoglobulin products.
Thorpe SJ; Fox B; Heath A; Dolman C; Virata ML; Yu MW; Thorpe R
Vox Sang; 2005 May; 88(4):278-87. PubMed ID: 15877651
[TBL] [Abstract][Full Text] [Related]
6. Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method.
Thorpe SJ; Fox BJ; Dolman CD; Thorpe R
Biologicals; 2005 Jun; 33(2):111-6. PubMed ID: 15905100
[TBL] [Abstract][Full Text] [Related]
7. Increases in anti-Rh(D) titre following pregnancy.
Mollison PL
Vox Sang; 1994; 67(3):326. PubMed ID: 7863638
[No Abstract] [Full Text] [Related]
8. Efficient and safe definition of the rhesus-negative donor on the olympus PK 7200 without the indirect antiglobulin test for weak D.
Mertens G; Muylle L
Vox Sang; 1996; 70(4):237-8. PubMed ID: 9123933
[No Abstract] [Full Text] [Related]
9. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
[TBL] [Abstract][Full Text] [Related]
10. Comparison of conventional tube test with diamed gel microcolumn assay for anti-D titration.
Novaretti MC; Jens E; Pagliarini T; Bonifácio SL; Dorlhiac-Llacer PE; Chamone DA
Clin Lab Haematol; 2003 Oct; 25(5):311-5. PubMed ID: 12974722
[TBL] [Abstract][Full Text] [Related]
11. International collaborative study to assess new stocks of candidate reference preparations to control the level of anti-D in IVIG.
Thorpe SJ; Virata ML; Fox B; Terao E
Pharmeur Bio Sci Notes; 2024; 2024():76-89. PubMed ID: 38949845
[TBL] [Abstract][Full Text] [Related]
12. An International Standard for specifying the minimum potency of anti-D blood-grouping reagents: evaluation of a candidate preparation in an international collaborative study.
Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A
Vox Sang; 2006 Feb; 90(2):131-9. PubMed ID: 16430672
[TBL] [Abstract][Full Text] [Related]
13. [Detection and side effects of isoantibodies in intravenously administered immunoglobulin preparations].
Strobel E; Wüllenweber J; Peters J
Infusionsther Transfusionsmed; 1995 Feb; 22(1):31-5. PubMed ID: 7727961
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a competitive radioimmunoassay using monoclonal antibodies against Rh D for determining anti-D potency of clinical grade immunoglobulin preparations.
Thorpe SJ; Heath AB
Transfus Med; 1995 Jun; 5(2):97-103. PubMed ID: 7655583
[TBL] [Abstract][Full Text] [Related]
15. Anti-A and anti-B haemagglutinin levels in intravenous immunoglobulins: are they on the rise? A comparison of four different analysis methods and six products.
Bellac CL; Polatti D; Hottiger T; Girard P; Sänger M; Gilgen M
Biologicals; 2014 Jan; 42(1):57-64. PubMed ID: 24325871
[TBL] [Abstract][Full Text] [Related]
16. Severe Hemolytic Anemia Following Intravenous Immunoglobulin in an Infant With Kawasaki Disease.
Tocan V; Inaba A; Kurano T; Sonoda M; Soebijanto K; Nakayama H
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e100-e102. PubMed ID: 27879540
[TBL] [Abstract][Full Text] [Related]
17. Has anti-D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility?
Dillon A; Chaudhari T; Crispin P; Shadbolt B; Kent A
J Paediatr Child Health; 2011 Jan; 47(1-2):40-3. PubMed ID: 20973864
[TBL] [Abstract][Full Text] [Related]
18. [A case study of leukemia with irregular anti-Ce IgG antibody].
Zhong GP; Shi W; Liao KM; Bi JQ; Sun Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):211-2. PubMed ID: 15841159
[TBL] [Abstract][Full Text] [Related]
19. Anti-red blood cell antibodies, free light chains, and antiphospholipid antibodies in intravenous immunoglobulin preparations.
Sakem B; Matozan K; Nydegger UE; Weigel G; Griesmacher A; Risch L
Isr Med Assoc J; 2013 Oct; 15(10):617-21. PubMed ID: 24266088
[TBL] [Abstract][Full Text] [Related]
20. [Anti-D human immunoglobulin test].
Kajiwara M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():795-7. PubMed ID: 20942192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
